Get started
Author

Doug Grove

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
2013 · Scott M. Hammer, Magdalena E. Sobieszczyk, et al. · New England Journal of Medicine · 622
PDF
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults
2021 · Glenda E. Gray, Linda-Gail Bekker, et al. · New England Journal of Medicine · 233
PDF
Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies
2015 · Wilton B. Williams, Hua-Xin Liao, et al. · Science · 205
A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
2011 · Gavin J. Churchyard, Cecilia Morgan, et al. · PLoS ONE · 142
PDF
Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk
2022 · Zoe Moodie, One Dintwe, et al. · The Journal of Infectious Diseases · 54
PDF
Sexually transmitted infections amongst men who have sex with men (MSM) in South Africa
2023 · Rujeko Mashingaidze, Zoe Moodie, et al. · PLOS Global Public Health · 22
Intentions to Use Preexposure Prophylaxis Among Current Phase 2B Preventive HIV-1 Vaccine Efficacy Trial Participants
2013 · Jonathan D. Fuchs, Magdalena E. Sobieszczyk, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 19
A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru
2019 · Michele Andrasik, Doug Grove, et al. · Vaccine · 6
Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data
2025 · Shelly Karuna, Fatima Laher, et al. · Journal of the International AIDS Society · 5
PDF
Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915)
2019 · Maria P. Lemos, Erica Lazarus, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 5
PDF
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa
2023 · Mookho Malahleha, Fatima Laher, et al. · AIDS and Behavior · 4
PDF
Transgender Participants in the HIV Vaccine Trial Network's HVTN 505 Trial: A Descriptive and Comparative Analysis
2014 · Shelly T. Karuna, Doug Grove, et al. · AIDS Research and Human Retroviruses · 1
seqDesign: Simulation and Group Sequential Monitoring of Randomized Two-Stage Treatment Efficacy Trials with Time-to-Event Endpoints
2014 · Michal Juraska, Doug Grove · 1
PDF
Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data
2025 · deCamp, Allan C., Grove, Doug, et al. · UNC Libraries
Simulation and Group Sequential Monitoring of Randomized Two-Stage Treatment Efficacy Trials with Time-to-Event Endpoints [R package seqDesign version 1.2]
2019 · Michal Juraska, Doug Grove
Works count: 16
Citation count: 1,314
H-index: 7
I10-index: 7
Year
Topic
Type